Johnson & Johnson said that CEO William Weldon is stepping down from that role in April, a move that ends Weldon's tenure during a period when the healthcare company has been beset by product recalls and lawsuits.
Gorsky succeeding Weldon as J&J CEO
Alex Gorsky, vice chairman of the executive committee, has been tapped to succeed Weldon as CEO of the New Brunswick, N.J.-based company and chairman of the executive committee, according to a Johnson & Johnson news release.
Gorsky, 51, currently oversees medical devices and diagnostics, global supply chain, healthcare compliance and privacy, and government affairs and policy.
“This succession decision involved a rigorous, thorough and formal multiyear process, which included consideration of two superbly qualified internal candidates, as well as outside candidates,” Weldon said in the news release.
Weldon, who is 63, served as CEO for 10 years. He will remain chairman of the board.
Johnson & Johnson expanded the executive committee in December 2010 when it named Gorsky and another executive, Sheri McCoy, as vice chairmen. McCoy oversees the pharmaceuticals and consumer groups, and information technology.
Weldon ranked No. 8 on Modern Healthcare's 2011 list of the 100 Most Influential People in Healthcare.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.